HOME >> MEDICINE >> NEWS
Cedars-Sinai Medical News Tips

Welcome to the inaugural edition of Cedars-Sinai Medical Center's "Top Tips." This semi-monthly service is designed especially for health and medical reporters and is offered free of charge by the Cedars-Sinai Medical Center Public Relations Department. To receive "Top Tips" twice each month via e-mail, please send your name, organization, phone and fax numbers, plus e-mail address, to sandy@vancommunications.com. If you are already receiving this service and do not wish to, you may cancel by sending to the same e-mail address with the word "unsubscribe" entered in the subject field. To pursue any of these story ideas, call 1-800-396-1002. Thank you.

DIABETES DRUG AND ACCUTANE BLOCK BREAST CANCER CELL GROWTH
Breast cancer cells exposed to a diabetes drug (Troglitazone) and the Vitamin A compound Accutane stopped multiplying and died on cue in laboratory and animal studies conducted at Cedars-Sinai Medical Center. The drug combination appears to have no adverse effect on healthy cells, either in laboratory studies or in immunodeficient mice injected with human breast cells that form tumors.
Interview: H. Phillip Koeffler, M.D., Director of Hematology/Oncology, Cedars-Sinai

NEW BRAIN TUMOR SUPPORT GROUP OFFERS PATIENTS AND FAMILIES MONTHLY UPDATES ON NEW TREATMENT OPTIONS PLUS PSYCHOLOGICAL SUPPORT
A new Brain Tumor Support Group at Cedars-Sinai Medical Center's Neurosurgical Institute provides patients and their families with psychological support as well as monthly updates on the latest in treatment options, including radiation, chemotherapy and future strategies using gene therapy and immunology. The series of programs combines medical updates with psychological support groups.
Interview: World-renowned brain surgeon Keith L. Black, M.D., and brain tumor patients

CLINICAL TRIALS AT CEDARS-SINAI OFFER NEW OPTION FOR ANGINA PAIN SUFFERERS
Cardiac patients who are t
'"/>

Contact: Sandra Van or Roberta Nichols
sandy@vancommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
27-Aug-1998


Page: 1 2

Related medicine news :

1. Cedars-Sinai medical tipsheet for Dec. 2004
2. Cedars-Sinai October 2004 medical tipsheet
3. Cedars-Sinai Medical tipsheet for May 2004
4. Cedars-Sinai receives full AAHRPP accreditation for all research involving human subjects
5. Cedars-Sinai March medical tipsheet
6. Cedars-Sinai researchers identify a gene that causes insulin resistance in Mexican Americans
7. Medical geneticist at Cedars-Sinai awarded $8.5 million NIH research grant
8. Cedars-Sinai researchers detail events that enable brain tumors to weaken immune system
9. Cedars-Sinai Medical tipsheet for July 2003
10. Cedars-Sinai researchers to present findings at Amerian College of Cardiology Scientific Meeting
11. Patients who need cardiac resynchronization therapy may be eligible for Cedars-Sinai clinical trials

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cedars Sinai Medical News Tips

(Date:7/25/2014)... July 25, 2014 Splashtop, Inc. announced ... Program . Splashtop Business and Splashtop Enterprise will now ... will leverage the MaaS360 WorkPlace SDK to enable enterprise-grade ... Business and Splashtop Enterprise offer secure remote access, support, ... High performance, ease of use, collaborative features, and ...
(Date:7/25/2014)... 2014 Training Mask LLC, is proud ... an endorsement agreement to promote the mask and its’ ... for over 10 years, and ran over 30 ultra ... of the Angeles Crest 100-mile endurance run. Brian is ... of the endurance, strength and conditioning paradigm. He created ...
(Date:7/25/2014)... An alpha olefin is an olefin or an ... alpha position of the carbon chain, or between the 1st ... namely, branched and linear (or normal). The alpha olefin market ... its applications such as polyethylene co-monomers and synthetic lubricants, across ... Europe have been lucrative markets for alpha olefins; however, Asia-Pacific ...
(Date:7/25/2014)... -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) ... Patent Pool (MPP) and Gilead Sciences, Inc. to ... promising new HIV medication. The agreement was announced ... in Melbourne, Australia. , While TAF is ... suggests it could be a key ingredient in ...
(Date:7/25/2014)... 2014 Ross A. Clevens, MD, FACS, ... to join the exclusive Obagi Clinical Advisory Board, comprised ... surgeons, plastic surgeons and dermatologists. , Dr. Clevens ... Board of thought leaders held its first meeting in ... to give Obagi the opportunity to meet with eight ...
Breaking Medicine News(10 mins):Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 2Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 3Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 4Health News:Training Mask LLC Announces the Signing of World-Renowned Coach Brian MacKenzie 2Health News:Training Mask LLC Announces the Signing of World-Renowned Coach Brian MacKenzie 3Health News:Europe Alpha Olefins Market is Expected to Reach $1,958 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Alpha Olefins Market is Expected to Reach $1,958 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2
(Date:7/24/2014)... July 24, 2014  Kinex Pharmaceuticals announced the receipt ... Company,s KX2-391 Ointment for the commencement of a Phase ... Company,s third IND to be allowed by the US ... is a synthetic, orally active and highly selective inhibitor ... promotes the induction of p53, G2/M arrest of proliferating ...
(Date:7/24/2014)...  The American Association for Homecare (AAHomecare) yesterday ... help address audit issues in the HME industry ... the information technology lead in shaping its HME ... billing and business management solutions for nearly 3,000 ... support this important initiative on behalf of all ...
(Date:7/24/2014)... Research and Markets  has announced the ... Product, Component, Application and Geography - Global Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 ... a moderate growth as the markets of the U.S. ... the saturation levels. The demand is expected to come ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2
Cached News: